NSCLC

May 09, 2025

ENHERTU’s Rapid Rise: How the HER2-Targeting ADC Is Redefining Cancer Treatment with Back-to-Back Label Expansions

May 09, 2025

ADCs in Lung Cancer Treatment: ENHERTU’s Rise, HER3 & TROP-2 Challenges, and What’s Next in the Pipeline

Apr 28, 2025

European Lung Cancer Congress (ELCC) 2025 Recap: Advances in Lung Cancer Research and Treatment

Mar 28, 2025

8 Emerging Bispecific Antibodies Transforming NSCLC Treatment

Dec 13, 2024

AstraZeneca’s IMFINZI Archives Another Milestone — Becomes the First Immunotherapy for Limited-Stage Small-cell Lung Cancer

Nov 29, 2024

Evaluating Key Advancements and Emerging Therapies in EGFR-Non Small Cell Lung Cancer Treatment Market

Nov 29, 2024

Novel Mutation-Targeting Therapies in the Horizon to Relieve the Global Healthcare Burden NSCLC Poses

Nov 29, 2024

Evolving Landscape for Rare Biomarkers in Non-Small Cell Lung Cancer

Nov 29, 2024

The Next Chapter in NSCLC Treatment Space: Recent Discoveries and Innovations

Nov 29, 2024

Non-Small Cell Lung Cancer Market: Treatments and Market Forecast

Newsletter/Whitepaper